Suppr超能文献

格林-巴利综合征的两种可能病因:mRNA-1273(莫德纳)疫苗接种和恙虫病:病例报告。

Two possible etiologies of Guillain-Barré syndrome: mRNA-1273 (Moderna) vaccination and scrub typhus: A case report.

机构信息

Department of Neurology, Chosun University School of Medicine, Gwangju, Republic of Korea.

出版信息

Medicine (Baltimore). 2022 Dec 2;101(48):e32140. doi: 10.1097/MD.0000000000032140.

Abstract

RATIONALE

Guillain-Barré syndrome (GBS) is an acute inflammatory polyneuropathy related to infection with bacteria or virus and vaccination. Cases of GBS after coronavirus infection-19 (COVID-19) vaccination have been reported. However, cases of GBS after inoculation with mRNA-based COVID-19 vaccines, especially mRNA-1273, have rarely been reported compared to after inoculation with adenovirus vector-based COVID-19 vaccines. On 1 hand, GBS occurring after scrub typhus is often reported, but the exact pathological mechanism has not been elucidated. We report the case of a patient with GBS after inoculation with mRNA-1273 COVID-19 vaccine and scrub typhus.

PATIENT CONCERNS

A 47-year-old man received COVID-19 vaccination 4 weeks before admission. He had a fever, rash and general weakness 1 day after vaccination. After 3 weeks, the muscle strength of the extremities deteriorated to the extent that walking was impossible.

DIAGNOSIS, INTERVENTIONS, AND OUTCOMES: The patient developed quadriplegia with areflexia, axonal-type sensorimotor polyneuropathy was confirmed by nerve conduction study. The patient was diagnosed as GBS. Scrub typhus was also diagnosed as eschar was observed in the chest area and the serologic test of anti-R-tsutsugamushi antibody showed a strongly positive result. The patient received treatment with intravenous immunoglobulin at 0.4 g/kg daily for 5 days. Mechanical ventilation was applied during the intensive care unit. He was treated for scrub typhus simultaneously. Six months after the onset of the disease, the patient showed improvement to the point where he could work and exercise alone.

LESSONS

When GBS is suspected, early evaluation and treatment can lead to favorable outcomes. Considering that cases of GBS after COVID-19 vaccination have been reported, it is important to conduct early evaluation and management of patients with muscle weakness after COVID-19 vaccination to ensure early detection of GBS. And even if fever and rash are side effects that can occur frequently after vaccination, it is necessary to consider other diseases in addition to the side effects of the vaccine. This is to prevent delay in diagnosis and treatment of other diseases.

摘要

背景

吉兰-巴雷综合征(GBS)是一种与细菌或病毒感染和疫苗接种相关的急性炎症性多神经病。有报道称,接种新冠病毒疫苗后会出现 GBS。然而,与接种腺病毒载体 COVID-19 疫苗相比,接种基于 mRNA 的 COVID-19 疫苗(尤其是 mRNA-1273)后出现 GBS 的病例则很少见。一方面,接种钩端螺旋体疫苗后常报告发生 GBS,但确切的病理机制尚未阐明。我们报告了一例接种 mRNA-1273 COVID-19 疫苗和恙虫病后发生 GBS 的病例。

病例描述

一名 47 岁男性,在入院前 4 周接种了 COVID-19 疫苗。他在接种疫苗后 1 天出现发热、皮疹和全身无力。3 周后,四肢肌肉力量恶化到无法行走的程度。

诊断、干预和结果:患者出现四肢瘫痪伴反射消失,神经传导研究证实为轴索性感觉运动性多神经病。患者被诊断为 GBS。同时也诊断为恙虫病,因为在胸部区域观察到焦痂,血清抗 R-恙虫病抗体检测结果呈强阳性。患者接受了 5 天 0.4 g/kg 剂量的静脉免疫球蛋白治疗。在重症监护病房期间应用了机械通气。同时对恙虫病进行了治疗。疾病发作后 6 个月,患者病情改善,可以独自工作和锻炼。

教训

当怀疑出现 GBS 时,早期评估和治疗可带来良好的结局。鉴于已报告接种 COVID-19 疫苗后出现 GBS 的病例,因此,对 COVID-19 疫苗接种后出现肌无力的患者进行早期评估和管理以确保早期发现 GBS 非常重要。即使发热和皮疹是疫苗接种后常发生的副作用,除了疫苗的副作用之外,还需要考虑其他疾病。这是为了防止延误其他疾病的诊断和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b59/9726323/2503a2b8425a/medi-101-e32140-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验